{"id":353110,"date":"2026-11-18T15:38:18","date_gmt":"2026-11-18T10:08:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353110"},"modified":"2026-11-18T15:38:18","modified_gmt":"2026-11-18T10:08:18","slug":"branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/","title":{"rendered":"3 Branded Medicines Company, Cement Maker and Forgings Maker Stocks With a Strong Future Roadmap: Mankind Pharma, JK Lakshmi Cement and Bharat Forge"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Mankind Pharma, JK Lakshmi Cement and Bharat Forge: ROE of 10.6% to 11.7% and FY22 to FY26 revenue CAGR of 5.8% to 16.4%. Prices as of 17 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>medicine brand, cement and forging stocks<\/strong> to watch are <strong>Mankind Pharma<\/strong>, <strong>JK Lakshmi Cement<\/strong> and <strong>Bharat Forge<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>10.6% to 11.7%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 5.8% to 16.4%. Mankind Pharma leads on both return on equity at 11.7% and revenue growth at 16.4% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Medicine brand, cement and forging stocks bring together companies with a visible plan for the years ahead. Mankind Pharma, JK Lakshmi Cement and Bharat Forge cover a branded medicines company, a cement maker and a forgings maker.<\/p>\n<p>This list covers three medicine brand, cement and forging stocks with complete current figures: Mankind Pharma, JK Lakshmi Cement and Bharat Forge. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#What_Are_Medicine_Brand_Cement_and_Forging_Stocks\" title=\"What Are Medicine Brand, Cement and Forging Stocks?\">What Are Medicine Brand, Cement and Forging Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Medicine_Brand_Cement_and_Forging_Stocks_at_a_Glance\" title=\"Medicine Brand, Cement and Forging Stocks at a Glance\">Medicine Brand, Cement and Forging Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Why_Do_Medicine_Brand_Cement_and_Forging_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Medicine Brand, Cement and Forging Stocks Have a Strong Roadmap in India?\">Why Do Medicine Brand, Cement and Forging Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Why_Mankind_Pharma_Features_Among_These_Medicine_Brand_Cement_and_Forging_Stocks\" title=\"Why Mankind Pharma Features Among These Medicine Brand, Cement and Forging Stocks\">Why Mankind Pharma Features Among These Medicine Brand, Cement and Forging Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Why_JK_Lakshmi_Cement_Features_Among_These_Medicine_Brand_Cement_and_Forging_Stocks\" title=\"Why JK Lakshmi Cement Features Among These Medicine Brand, Cement and Forging Stocks\">Why JK Lakshmi Cement Features Among These Medicine Brand, Cement and Forging Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Why_Bharat_Forge_Features_Among_These_Medicine_Brand_Cement_and_Forging_Stocks\" title=\"Why Bharat Forge Features Among These Medicine Brand, Cement and Forging Stocks\">Why Bharat Forge Features Among These Medicine Brand, Cement and Forging Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Mankind_Pharma_vs_JK_Lakshmi_Cement_vs_Bharat_Forge_on_Key_Financials\" title=\"Mankind Pharma vs JK Lakshmi Cement vs Bharat Forge on Key Financials\">Mankind Pharma vs JK Lakshmi Cement vs Bharat Forge on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Key_Risks_to_Check_Before_Investing_in_Medicine_Brand_Cement_and_Forging_Stocks\" title=\"Key Risks to Check Before Investing in Medicine Brand, Cement and Forging Stocks\">Key Risks to Check Before Investing in Medicine Brand, Cement and Forging Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Final_Thoughts_on_Medicine_Brand_Cement_and_Forging_Stocks\" title=\"Final Thoughts on Medicine Brand, Cement and Forging Stocks\">Final Thoughts on Medicine Brand, Cement and Forging Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#What_are_medicine_brand_cement_and_forging_stocks\" title=\"What are medicine brand, cement and forging stocks?\">What are medicine brand, cement and forging stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Which_medicine_brand_cement_and_forging_stocks_are_covered_in_this_list\" title=\"Which medicine brand, cement and forging stocks are covered in this list?\">Which medicine brand, cement and forging stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Why_do_medicine_brand_cement_and_forging_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do medicine brand, cement and forging stocks have a strong future roadmap in India?\">Why do medicine brand, cement and forging stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#How_has_Mankind_Pharma_performed_financially\" title=\"How has Mankind Pharma performed financially?\">How has Mankind Pharma performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#How_has_JK_Lakshmi_Cement_performed_financially\" title=\"How has JK Lakshmi Cement performed financially?\">How has JK Lakshmi Cement performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#How_has_Bharat_Forge_performed_financially\" title=\"How has Bharat Forge performed financially?\">How has Bharat Forge performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#What_risks_should_investors_check_before_buying_medicine_brand_cement_and_forging_stocks\" title=\"What risks should investors check before buying medicine brand, cement and forging stocks?\">What risks should investors check before buying medicine brand, cement and forging stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/branded-medicines-company-cement-maker-and-forgings-maker-stocks-roadmap-steppeland-list\/#Is_this_list_of_medicine_brand_cement_and_forging_stocks_investment_advice\" title=\"Is this list of medicine brand, cement and forging stocks investment advice?\">Is this list of medicine brand, cement and forging stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Medicine_Brand_Cement_and_Forging_Stocks\"><\/span><strong>What Are Medicine Brand, Cement and Forging Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Medicine brand, cement and forging stocks<\/strong> are listed companies that make and sell branded medicines and consumer health products, make grey and white cement for homes and projects, and make forged and machined parts for vehicles, defence and industry. Their earnings depend on medicine demand, construction activity and vehicle and defence orders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medicine_Brand_Cement_and_Forging_Stocks_at_a_Glance\"><\/span><strong>Medicine Brand, Cement and Forging Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,610<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">93,014<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/jklakshmi\/jk-lakshmi-cement-ltd-share-price-today\">JK Lakshmi Cement<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">515.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,094<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/bharatforg\/bharat-forge-ltd-share-price-today\">Bharat Forge<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,714.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">87,540<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">122.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">50.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.76<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, JK Lakshmi Cement trades at a <strong>P\/E<\/strong> below the industry P\/E, while Mankind Pharma and Bharat Forge trade above it, which reflects the growth the market already expects. Readers comparing medicine brand, cement and forging stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in medicine brand, cement and forging stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Medicine_Brand_Cement_and_Forging_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Medicine Brand, Cement and Forging Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Medicine brand, cement and forging stocks<\/strong> have a strong roadmap in India because strong demand for branded medicines, steady home and road building and rising vehicle and defence orders keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Branded medicines.<\/strong> Doctors prescribe trusted brands.<\/li>\n<li><strong>Cement.<\/strong> Homes and roads need steady supply.<\/li>\n<li><strong>Forgings.<\/strong> Vehicles and defence need strong parts.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Mankind_Pharma_Features_Among_These_Medicine_Brand_Cement_and_Forging_Stocks\"><\/span><strong>Why Mankind Pharma Features Among These Medicine Brand, Cement and Forging Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the medicine brand, cement and forging stocks on this list, Mankind Pharma is one of India&#8217;s largest pharmaceutical companies by domestic sales, with a strong presence in chronic and acute therapies, consumer healthcare brands and a large field force.<\/p>\n<p>In the June 2026 quarter, revenue grew 11.7% year on year to Rs 4,076 crore, while net profit rose 29.1% to Rs 574 crore. Revenue rose from Rs 7,978 crore in FY22 to Rs 14,636 crore in FY26, a compound annual growth rate of 16.4%.<\/p>\n<p>Net profit grew from Rs 1,453 crore in FY22 to Rs 1,938 crore in FY26, which works out to a compound annual growth rate of 7.5%. The company has a return on equity of 11.7%, a debt to equity ratio of 0.39 and a <strong>market capitalisation<\/strong> of Rs 93,014 crore. The stock trades at a <strong>P\/E<\/strong> of 45.0, above the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company combines a wide field force with a portfolio of leading brands, and has added scale through the acquisition of Bharat Serums and Vaccines. New launches in chronic therapies and a growing consumer healthcare business broaden the base.<\/p>\n<p><strong>What to watch:<\/strong> Watch the market share in chronic therapies and the integration of acquired brands.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_JK_Lakshmi_Cement_Features_Among_These_Medicine_Brand_Cement_and_Forging_Stocks\"><\/span><strong>Why JK Lakshmi Cement Features Among These Medicine Brand, Cement and Forging Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the pharma leader, regional cement and auto forgings shares on this list, JK Lakshmi Cement makes grey cement and ready-mix concrete for customers in northern and western India, selling mainly through a strong dealer network under the JK Lakshmi brand.<\/p>\n<p>The company has a return on equity of 10.6%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 6,094 crore. The stock trades at a P\/E of 16.4, below the industry P\/E of 29.1.<\/p>\n<p>Revenue rose from Rs 5,488 crore in FY22 to Rs 6,875 crore in FY26, a compound annual growth rate of 5.8%. Net profit grew from Rs 276 crore in FY25 to Rs 413 crore in FY26, a rise of 49.5%. In the June 2026 quarter, revenue grew 8.9% year on year to Rs 1,920 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding cement and clinker capacity in the markets it serves and extending its reach through dealers. Housing and infrastructure projects in its home markets support volume growth.<\/p>\n<p><strong>What to watch:<\/strong> Check capacity expansion progress and volume growth in core regions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Bharat_Forge_Features_Among_These_Medicine_Brand_Cement_and_Forging_Stocks\"><\/span><strong>Why Bharat Forge Features Among These Medicine Brand, Cement and Forging Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Bharat Forge is a Pune-based maker of forgings, axles and chassis components for automotive and industrial customers, and it has a growing defence and aerospace business that includes artillery systems and components.<\/p>\n<p>Revenue rose from Rs 10,657 crore in FY22 to Rs 17,010 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew from Rs 508 crore in FY23 to Rs 1,089 crore in FY26, which works out to a compound annual growth rate of 28.9%.<\/p>\n<p>In the June 2026 quarter, revenue grew 18.7% year on year to Rs 4,697 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 87,540 crore. The stock trades at a P\/E of 122.4, above the industry P\/E of 50.7.<\/p>\n<p><strong>Roadmap:<\/strong> The company is widening its mix beyond automotive into defence, aerospace and industrial products, where programmes run for many years. Its forging expertise and global customer base support a range of applications.<\/p>\n<p><strong>What to watch:<\/strong> Check order inflow in defence and aerospace and the share of non-automotive sales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_vs_JK_Lakshmi_Cement_vs_Bharat_Forge_on_Key_Financials\"><\/span><strong>Mankind Pharma vs JK Lakshmi Cement vs Bharat Forge on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three medicine brand, cement and forging stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Mankind Pharma<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,978<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,636<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,938<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">JK Lakshmi Cement<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,488<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,875<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">413<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Bharat Forge<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,657<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17,010<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,089<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Mankind Pharma posts the highest return on equity in this group at 11.7%. Bharat Forge has the largest FY26 revenue at Rs 17,010 crore, and Mankind Pharma shows the fastest revenue growth with a 16.4% compound annual rate. A useful habit with <strong>medicine brand, cement and forging stocks<\/strong> is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Mankind Pharma<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,650<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,076<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">JK Lakshmi Cement<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,763<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,920<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Bharat Forge<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,958<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,697<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Medicine_Brand_Cement_and_Forging_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Medicine Brand, Cement and Forging Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these medicine brand, cement and forging stocks, the main points are: Long-term pharma leader, regional cement and auto forgings shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Input costs.<\/strong> Metal and material prices can move margins.<\/li>\n<li><strong>Order timing.<\/strong> Defence and space orders can shift between periods.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter medicine brand, cement and forging stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Medicine_Brand_Cement_and_Forging_Stocks\"><\/span><strong>Final Thoughts on Medicine Brand, Cement and Forging Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Medicine brand, cement and forging stocks<\/strong> suit investors who prefer to study business strength before price moves. Mankind Pharma, JK Lakshmi Cement and Bharat Forge each have a clear plan to grow. Based on the 17 November 2026 close, Mankind Pharma trades at Rs 2,610, JK Lakshmi Cement at Rs 515.9 and Bharat Forge at Rs 1,714.7. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these medicine brand, cement and forging stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track medicine brand, cement and forging stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_medicine_brand_cement_and_forging_stocks\"><\/span><strong>What are medicine brand, cement and forging stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicine brand, cement and forging stocks are listed companies that make and sell branded medicines and consumer health products, make grey and white cement for homes and projects, and make forged and machined parts for vehicles, defence and industry. Their earnings depend on medicine demand, construction activity and vehicle and defence orders. This list looks at three of them, Mankind Pharma, JK Lakshmi Cement and Bharat Forge, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_medicine_brand_cement_and_forging_stocks_are_covered_in_this_list\"><\/span><strong>Which medicine brand, cement and forging stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Mankind Pharma, JK Lakshmi Cement and Bharat Forge. Based on the 17 November 2026 close, Mankind Pharma traded at Rs 2,610, JK Lakshmi Cement at Rs 515.9 and Bharat Forge at Rs 1,714.7. Their return on equity ranges from <strong>10.6% to 11.7%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 5.8% to 16.4%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_medicine_brand_cement_and_forging_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do medicine brand, cement and forging stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Medicine brand, cement and forging stocks<\/strong> have a strong roadmap in India because strong demand for branded medicines, steady home and road building and rising vehicle and defence orders keep widening the market for these companies. The main drivers are as follows. Branded medicines. Doctors prescribe trusted brands. Cement. Homes and roads need steady supply. Forgings. Vehicles and defence need strong parts. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Mankind_Pharma_performed_financially\"><\/span><strong>How has Mankind Pharma performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 7,978 crore in FY22 to Rs 14,636 crore in FY26, a compound annual growth rate of 16.4%. Net profit grew from Rs 1,453 crore in FY22 to Rs 1,938 crore in FY26, which works out to a compound annual growth rate of 7.5%. In the June 2026 quarter, revenue grew 11.7% year on year to Rs 4,076 crore, while net profit rose 29.1% to Rs 574 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.39 and a market capitalisation of Rs 93,014 crore. The stock trades at a P\/E of 45.0, above the industry P\/E of 36.0. Looking ahead, the company combines a wide field force with a portfolio of leading brands, and has added scale through the acquisition of Bharat Serums and Vaccines. New launches in chronic therapies and a growing consumer healthcare business broaden the base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_JK_Lakshmi_Cement_performed_financially\"><\/span><strong>How has JK Lakshmi Cement performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 5,488 crore in FY22 to Rs 6,875 crore in FY26, a compound annual growth rate of 5.8%. Net profit grew from Rs 276 crore in FY25 to Rs 413 crore in FY26, a rise of 49.5%. In the June 2026 quarter, revenue grew 8.9% year on year to Rs 1,920 crore. The company has a return on equity of 10.6%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 6,094 crore. The stock trades at a P\/E of 16.4, below the industry P\/E of 29.1. Looking ahead, the company is adding cement and clinker capacity in the markets it serves and extending its reach through dealers. Housing and infrastructure projects in its home markets support volume growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Bharat_Forge_performed_financially\"><\/span><strong>How has Bharat Forge performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 10,657 crore in FY22 to Rs 17,010 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew from Rs 508 crore in FY23 to Rs 1,089 crore in FY26, which works out to a compound annual growth rate of 28.9%. In the June 2026 quarter, revenue grew 18.7% year on year to Rs 4,697 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 87,540 crore. The stock trades at a P\/E of 122.4, above the industry P\/E of 50.7. Looking ahead, the company is widening its mix beyond automotive into defence, aerospace and industrial products, where programmes run for many years. Its forging expertise and global customer base support a range of applications.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_medicine_brand_cement_and_forging_stocks\"><\/span><strong>What risks should investors check before buying medicine brand, cement and forging stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying medicine brand, cement and forging stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Input costs. Metal and material prices can move margins. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_medicine_brand_cement_and_forging_stocks_investment_advice\"><\/span><strong>Is this list of medicine brand, cement and forging stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are medicine brand, cement and forging stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicine brand, cement and forging stocks are listed companies that make and sell branded medicines and consumer health products, make grey and white cement for homes and projects, and make forged and machined parts for vehicles, defence and industry. Their earnings depend on medicine demand, construction activity and vehicle and defence orders. This list looks at three of them, Mankind Pharma, JK Lakshmi Cement and Bharat Forge, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which medicine brand, cement and forging stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Mankind Pharma, JK Lakshmi Cement and Bharat Forge. Based on the 17 November 2026 close, Mankind Pharma traded at Rs 2,610, JK Lakshmi Cement at Rs 515.9 and Bharat Forge at Rs 1,714.7. Their return on equity ranges from 10.6% to 11.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.8% to 16.4%.\"}},{\"@type\":\"Question\",\"name\":\"Why do medicine brand, cement and forging stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicine brand, cement and forging stocks have a strong roadmap in India because strong demand for branded medicines, steady home and road building and rising vehicle and defence orders keep widening the market for these companies. The main drivers are as follows. Branded medicines. Doctors prescribe trusted brands. Cement. Homes and roads need steady supply. Forgings. Vehicles and defence need strong parts. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Mankind Pharma performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 7,978 crore in FY22 to Rs 14,636 crore in FY26, a compound annual growth rate of 16.4%. Net profit grew from Rs 1,453 crore in FY22 to Rs 1,938 crore in FY26, which works out to a compound annual growth rate of 7.5%. In the June 2026 quarter, revenue grew 11.7% year on year to Rs 4,076 crore, while net profit rose 29.1% to Rs 574 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.39 and a market capitalisation of Rs 93,014 crore. The stock trades at a P\/E of 45.0, above the industry P\/E of 36.0. Looking ahead, the company combines a wide field force with a portfolio of leading brands, and has added scale through the acquisition of Bharat Serums and Vaccines. New launches in chronic therapies and a growing consumer healthcare business broaden the base.\"}},{\"@type\":\"Question\",\"name\":\"How has JK Lakshmi Cement performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 5,488 crore in FY22 to Rs 6,875 crore in FY26, a compound annual growth rate of 5.8%. Net profit grew from Rs 276 crore in FY25 to Rs 413 crore in FY26, a rise of 49.5%. In the June 2026 quarter, revenue grew 8.9% year on year to Rs 1,920 crore. The company has a return on equity of 10.6%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 6,094 crore. The stock trades at a P\/E of 16.4, below the industry P\/E of 29.1. Looking ahead, the company is adding cement and clinker capacity in the markets it serves and extending its reach through dealers. Housing and infrastructure projects in its home markets support volume growth.\"}},{\"@type\":\"Question\",\"name\":\"How has Bharat Forge performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 10,657 crore in FY22 to Rs 17,010 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew from Rs 508 crore in FY23 to Rs 1,089 crore in FY26, which works out to a compound annual growth rate of 28.9%. In the June 2026 quarter, revenue grew 18.7% year on year to Rs 4,697 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 87,540 crore. The stock trades at a P\/E of 122.4, above the industry P\/E of 50.7. Looking ahead, the company is widening its mix beyond automotive into defence, aerospace and industrial products, where programmes run for many years. Its forging expertise and global customer base support a range of applications.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying medicine brand, cement and forging stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying medicine brand, cement and forging stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Input costs. Metal and material prices can move margins. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of medicine brand, cement and forging stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medicine Brand, Cement and Forging Stocks with a strong future roadmap: Mankind Pharma, JK Lakshmi Cement and Bharat Forge. Compare price, valuation, return on equity and revenue growth as of 17 November 2026.<\/p>\n","protected":false},"author":38,"featured_media":353109,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,6007,22856,25849,25846,9964,805,25845,25847,25848],"class_list":["post-353110","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-bharat-forge","tag-branded-drugs","tag-building-material-and-forged-parts-stocks","tag-cement-and-forging-stocks","tag-jk-lakshmi-cement","tag-mankind-pharma","tag-medicine-brand","tag-pharma-leader","tag-regional-cement-and-auto-forgings-shares"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353109"],"rank_math_title":["Medicine Brand, Cement and Forging Stocks"],"rank_math_description":["Compare 3 medicine brand, cement and forging stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 17 Nov 2026."],"rank_math_focus_keyword":["medicine brand, cement and forging stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-branded-medicines-company-cement-maker-and-forgings-maker-stocks-with-a-strong.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353110"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353110\/revisions"}],"predecessor-version":[{"id":353111,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353110\/revisions\/353111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353109"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}